Faithward Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,186
Closed -$342K 289
2021
Q3
$342K Sell
1,186
-882
-43% -$226K 0.07% 136
2021
Q2
$413K Sell
2,068
-9,838
-83% -$1.91M 0.08% 109
2021
Q1
$2.31M Buy
+11,906
New +$2.44M 0.52% 53

Other funds holding RGEN

Faithward Advisors's RGEN Position: Q4 2021 in Review

Faithward Advisors sold out of Repligen (RGEN) in Q4 2021, closing a stake of 1,186 shares — an estimated $342K sold.

Faithward Advisors first reported a position in RGEN in Q1 2021 and held it in 3 quarters. The position peaked at $2.31M in Q1 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Faithward Advisors reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Faithward Advisors sold 1,186 Repligen shares in Q4 2021, an estimated $342K.
  • Faithward Advisors first reported a position in Repligen in Q1 2021 and held it in 3 quarters.
  • Faithward Advisors's Repligen position peaked at $2.31M in Q1 2021.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Faithward Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.